価格表

在庫・価格 : 2024年04月20日 03時18分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
CytoSelect 24-well Wound Healing Assay Kit (24assays)
データシート
CBA-120 CBOセルバイオラボ
Cell Biolabs. Inc.
1 kit ¥166,000
(未発注)
追加

在庫・価格 : 2024年04月20日 03時18分 現在

CytoSelect 24-well Wound Healing Assay Kit (24assays)

  • 商品コード:CBA-120
  • メーカー:CBO
  • 包装:1kit
  • 価格: ¥166,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Oommen S et al. Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site. J. Biol. Chem. 2011 Jan;286(2):1083-
Oommen S et al
2011/01/01
PubMed
2 Cui XB et al. Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice. Cardiovasc. Res. 2013 Sep;99(4):632-9
Cui XB et al
2013/01/01
PubMed
3 Gutschner T et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013 Feb;73(3):1180-9
Gutschner T et al
2013/01/01
PubMed
4 Xing C et al. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma. Mol. Cancer Ther. 2013 Jan;12(1):94-103
Xing C et al
2013/01/01
PubMed
5 Mao L et al. Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β. Mol. Endocrinol. 2012 Nov;26(11):1808-20
Mao L et al
2012/01/01
PubMed
6 Walsh EM et al. Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesis. Neuro-oncology 2012 Jul;14(7):890-901
Walsh EM et al
2012/01/01
PubMed
7 Niu F et al. Tat 101-mediated enhancement of brain pericyte migration involves platelet-derived growth factor subunit B homodimer: implications for human immunodeficiency virus-associated neurocognitive disorders. J. Neurosci. 2014 Aug;34(35):11812-25
Niu F et al
2014/01/01
PubMed
8 Wang JN et al. Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration. Arterioscler. Thromb. Vasc. Biol. 2011 Aug;31(8):e19-26
Wang JN et al
2011/01/01
PubMed
9 Hirata H et al. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 2012 Jan;33(1):41-8
Hirata H et al
2012/01/01
PubMed
10 Buckley S et al. The milieu of damaged alveolar epithelial type 2 cells stimulates alveolar wound repair by endogenous and exogenous progenitors. Am. J. Respir. Cell Mol. Biol. 2011 Dec;45(6):1212-21
Buckley S et al
2011/01/01
PubMed
11 Tao Y et al. Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS. Nucleic Acids Res. 2011 Dec;39(22):9508-20
Tao Y et al
2011/01/01
PubMed
  • No.: 1
  • 文献情報:
    Oommen S et al. Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site. J. Biol. Chem. 2011 Jan;286(2):1083-
    Oommen S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Cui XB et al. Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice. Cardiovasc. Res. 2013 Sep;99(4):632-9
    Cui XB et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Gutschner T et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013 Feb;73(3):1180-9
    Gutschner T et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Xing C et al. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma. Mol. Cancer Ther. 2013 Jan;12(1):94-103
    Xing C et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Mao L et al. Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β. Mol. Endocrinol. 2012 Nov;26(11):1808-20
    Mao L et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Walsh EM et al. Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesis. Neuro-oncology 2012 Jul;14(7):890-901
    Walsh EM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Niu F et al. Tat 101-mediated enhancement of brain pericyte migration involves platelet-derived growth factor subunit B homodimer: implications for human immunodeficiency virus-associated neurocognitive disorders. J. Neurosci. 2014 Aug;34(35):11812-25
    Niu F et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wang JN et al. Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration. Arterioscler. Thromb. Vasc. Biol. 2011 Aug;31(8):e19-26
    Wang JN et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Hirata H et al. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 2012 Jan;33(1):41-8
    Hirata H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Buckley S et al. The milieu of damaged alveolar epithelial type 2 cells stimulates alveolar wound repair by endogenous and exogenous progenitors. Am. J. Respir. Cell Mol. Biol. 2011 Dec;45(6):1212-21
    Buckley S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Tao Y et al. Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS. Nucleic Acids Res. 2011 Dec;39(22):9508-20
    Tao Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed